mailed
on 25 Nov 2022
Last Applicant/ Owned by
10 Stratton Street
London
GB
W1J8LG
Serial Number
90886631 filed on 17th Aug 2021
Registration Number
N/A
Correspondent Address
S. Roxanne Edwards BELL NUNNALLY & MARTIN LLP
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Medical and pharmacological research services; biological research; clinical research in the field of oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and surgery in relation to cancer; medical research; providing an online network environment for research aRead More
Medical and pharmacological research services; biological research; clinical research in the field of oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and surgery in relation to cancer; medical research; providing an online network environment for research and development for drug and pharmaceutical development; providing an online network environment for the design, development and testing of drugs and pharmaceuticals; Providing scientific and technological services and research, analysis, and design relating thereto; design, development and testing of drugs and pharmaceuticals for the treatment and/or prevention of cancer; laboratory research into new drugs and pharmaceutical products; pharmaceutical drug development services; research relating into medicines; consultancy services relating to scientific and medical research; expert advice relating to drug development, being consulting services in the field of pharmaceutical research; laboratory analysis in the field of pharmaceutical research; computer hardware and software design and development in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; computer network services in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; software hosting services in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; software as a service in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; Information Technology (IT) consultancy, advisory and information services relating to a network of medical research professionals; scientific advisory services; scientific research projects and studies being scientific research and development; conducting clinical trials being scientific and medical research for others; scientific and medical clinical research for others; clinical research for cancer treatments and pharmaceuticals; providing an online network environment for clinical trials; conducting and collating a research network for treatment, cure and prevention of cancer being medical and scientific research; development of measuring and testing methods being research and development in the field of pharmaceuticals; quality control of services; evaluation of drug development services; industrial testing, namely, industrial design services; pharmaceutical product evaluation; testing of chemicals
11th 000101
11th 000101
Pharmaceutical preparations for the treatment of cancer; veterinary preparations for the treatment of cancer; dietetic preparations for medical purposes; dietetic foods for use in clinical nutrition; food supplements; nutraceuticals for therapeutic and medical purposes; medicated food supplements; biological preparations for the treatment of cancer; anti-cancer preparations; anti-cancer drugs being preparations; compounds for treating cancer being pharmaceutical preparations; biopharmaceuticals for the treatment of cancer; anti-cancer preparations of chemical origin; anti-cancer preparations of plant origin; anti-cancer preparations of microbial origin; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations from hormones and antagonists; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; all of the aforesaid for use in oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to cancer
11th 000101
11th 000101
No 90886631
No Service Mark
No 12900.00004
Yes
Yes
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 07th May 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVE |
| 29th Dec 2023 | SUSPENSION CHECKE - TO ATTORNEY OR ACTION |
| 08th Jun 2023 | SUSPENSION CHECKE - TO ATTORNEY OR ACTION |
| 25th Nov 2022 | NOTIICATION O LETTER O SUSPENSION E-MAILE |
| 25th Nov 2022 | LETTER O SUSPENSION E-MAILE |
| 25th Nov 2022 | SUSPENSION LETTER WRITTEN |
| 24th Nov 2022 | TEAS/EMAIL CORRESPONENCE ENTERE |
| 23rd Nov 2022 | TEAS RESPONSE TO OICE ACTION RECEIVE |
| 23rd Nov 2022 | CORRESPONENCE RECEIVE IN LAW OICE |
| 23rd May 2022 | NON-INAL ACTION WRITTEN |
